These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 24369739

  • 1. Antiretroviral treatment and quality of life in Africans living with HIV: 12-month follow-up in Burkina Faso.
    Jaquet A, Garanet F, Balestre E, Ekouevi DK, Azani JC, Bognounou R, Dah E, Kondombo JC, Dabis F, Drabo J.
    J Int AIDS Soc; 2013 Dec 18; 16(1):18867. PubMed ID: 24369739
    [Abstract] [Full Text] [Related]

  • 2. Health-related quality of life and associated factors in people with HIV: an Irish cohort study.
    George S, Bergin C, Clarke S, Courtney G, Codd MB.
    Health Qual Life Outcomes; 2016 Aug 05; 14(1):115. PubMed ID: 27495166
    [Abstract] [Full Text] [Related]

  • 3. Quality of life in persons living with HIV in Burkina Faso: a follow-up over 12 months.
    Bakiono F, Guiguimdé PW, Sanou M, Ouédraogo L, Robert A.
    BMC Public Health; 2015 Nov 13; 15():1119. PubMed ID: 26563970
    [Abstract] [Full Text] [Related]

  • 4. Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study.
    Kouanda S, Meda IB, Nikiema L, Tiendrebeogo S, Doulougou B, Kaboré I, Sanou MJ, Greenwell F, Soudré R, Sondo B.
    AIDS Care; 2012 Nov 13; 24(4):478-90. PubMed ID: 22148973
    [Abstract] [Full Text] [Related]

  • 5. Socio-economic, behavioural, (neuro)psychological and clinical determinants of HRQoL in people living with HIV in Belgium: a pilot study.
    Degroote S, Vogelaers DP, Vermeir P, Mariman A, De Rick A, Van Der Gucht B, Pelgrom J, Van Wanzeele F, Verhofstede C, Vandijck DM.
    J Int AIDS Soc; 2013 Dec 12; 16(1):18643. PubMed ID: 24331754
    [Abstract] [Full Text] [Related]

  • 6. Quality of life of HIV patients in a rural area of western Uganda: impact of a community-based antiretroviral treatment program.
    Alibhai A, Martin LJ, Kipp W, Konde-Lule J, Saunders LD, Rubaale T, Houston S, Okech-Ojony J.
    Curr HIV Res; 2010 Jul 12; 8(5):370-8. PubMed ID: 20353388
    [Abstract] [Full Text] [Related]

  • 7. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
    Kouanda S, Tougri H, Cisse M, Simpore J, Pietra V, Doulougou B, Ouedraogo G, Ouedraogo CM, Soudre R, Sondo B.
    AIDS Care; 2010 Jul 12; 22(7):843-50. PubMed ID: 20635248
    [Abstract] [Full Text] [Related]

  • 8. Clinical and immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa.
    Focà E, Odolini S, Sulis G, Calza S, Pietra V, Rodari P, Giorgetti PF, Noris A, Ouedraogo P, Simpore J, Pignatelli S, Castelli F.
    BMC Infect Dis; 2014 Mar 21; 14():153. PubMed ID: 24656065
    [Abstract] [Full Text] [Related]

  • 9. Predictors of health-related quality of life among military HIV-infected individuals.
    Emuren L, Welles S, Macalino G, Evans AA, Polansky M, Ganesan A, Colombo RE, Agan BK, Infectious Disease Clinical Research Program HIV Working Group.
    Qual Life Res; 2020 Jul 21; 29(7):1855-1869. PubMed ID: 32076926
    [Abstract] [Full Text] [Related]

  • 10. Health-related quality of life outcomes in HIV-infected patients starting different combination regimens in a randomized multinational trial: the INITIO-QoL substudy.
    Bucciardini R, Fragola V, Massella M, Polizzi C, Mirra M, Goodall R, Carey D, Hudson F, Zajdenverg R, Floridia M, Initio Trial International Coordinating Committee.
    AIDS Res Hum Retroviruses; 2007 Oct 21; 23(10):1215-22. PubMed ID: 17961107
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Measuring quality of life in rural Uganda: reliability and validity of summary scores from the medical outcomes study HIV health survey (MOS-HIV).
    Stangl AL, Bunnell R, Wamai N, Masaba H, Mermin J.
    Qual Life Res; 2012 Nov 21; 21(9):1655-63. PubMed ID: 22198741
    [Abstract] [Full Text] [Related]

  • 13. [Polyneuropathies in patients treated with HAART in Bobo-Dioulasso hospital, Burkina Faso].
    Millogo A, Lankoandé D, Yaméogo I, Yaméogo AA, Sawadogo AB.
    Bull Soc Pathol Exot; 2008 Feb 21; 101(1):11-3. PubMed ID: 18431998
    [Abstract] [Full Text] [Related]

  • 14. Impacts of HIV infection and HAART use on quality of life.
    Liu C, Ostrow D, Detels R, Hu Z, Johnson L, Kingsley L, Jacobson LP.
    Qual Life Res; 2006 Aug 21; 15(6):941-9. PubMed ID: 16900275
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Changes and determinants of health-related quality of life among people newly diagnosed with HIV in China: a 1-year follow-up study.
    Huang Y, Luo D, Chen X, Zhang D, Wang M, Qiu Y, Liu Y, Peng B, Niu L, Xiao S.
    Qual Life Res; 2019 Jan 21; 28(1):35-46. PubMed ID: 30206817
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico-vaginal HIV-1 RNA among women in Burkina Faso.
    Nagot N, Ouedraogo A, Weiss HA, Konate I, Sanon A, Defer MC, Sawadogo A, Andonaba JB, Vallo R, Becquart P, Segondy M, Mayaud P, Van de Perre P, Yerelon Study Group.
    Sex Transm Infect; 2008 Jun 21; 84(3):167-70. PubMed ID: 18055582
    [Abstract] [Full Text] [Related]

  • 18. Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.
    Dembélé M, Saleri N, Carvalho AC, Saouadogo T, Hien AD, Zabsonre I, Koala ST, Simporé J, Matteelli A.
    Int J Tuberc Lung Dis; 2010 Mar 21; 14(3):318-23. PubMed ID: 20132623
    [Abstract] [Full Text] [Related]

  • 19. Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine and/or efavirenz.
    van Leth F, Conway B, Laplumé H, Martin D, Fisher M, Jelaska A, Wit FW, Lange JM, 2NN study group.
    Antivir Ther; 2004 Oct 21; 9(5):721-8. PubMed ID: 15535409
    [Abstract] [Full Text] [Related]

  • 20. Characteristics and factors associated with the clinical forms of lipoatrophy during highly active antiretroviral therapy in Ouagadougou, Burkina Faso.
    Guira O, Tiéno H, Yaméogo B, Diendéré AE, Korsaga N, Sagna Y, Zoungrana L, Diallo I, Traoré R, Drabo JY.
    J Int Assoc Provid AIDS Care; 2014 Oct 21; 13(2):184-7. PubMed ID: 24114724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.